This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (169) Clinical Cancer Research (116) Lung Cancer (66) Precision Medicine (159) Chemotherapy and Side Effects Management (110)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/64950, first published .
Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Efficacy and Safety of a Therapy Combining Sintilimab and Chemotherapy With Cryoablation in the First-Line Treatment of Advanced Nonsquamous Non–Small Cell Lung Cancer: Protocol for a Phase II, Pilot, Single-Arm, Single-Center Study

Authors of this article:

Zhiqiang Gao1 Author Orcid Image ;   Jiajun Teng1 Author Orcid Image ;   Rong Qiao1 Author Orcid Image ;   Jialin Qian1 Author Orcid Image ;   Feng Pan1 Author Orcid Image ;   Meili Ma1 Author Orcid Image ;   Jun Lu1 Author Orcid Image ;   Bo Zhang1 Author Orcid Image ;   Tianqing Chu1 Author Orcid Image ;   Hua Zhong1 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Chen X. PD-1 inhibitor therapy combined with argon-helium cryoablation is effective against non-small cell lung cancer. American Journal of Translational Research 2025;17(8):6122 View